1117P Overall survival (OS) in patients with metastatic BRAF V600-mutant melanoma treated with encorafenib plus binimetinib (ENCO+BINI): Comparing real-world vs clinical trial data
| Autor: | In, G.K., Chen, K., Sajeev, G., Simpson, R., Kalia, S., Christensen, D., Liu, D., Rezai, N., di Pietro, A., Signorovitch, J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S673-S673 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|